ZEO ScientifiX
Harry Leider, MD, MBA, currently serves as Chief Medical Officer at Hibiscus Health and Ash Wellness, focusing on AI-driven health screening and at-home diagnostic tests, respectively. In addition, Harry Leider operates as a fractional Chief Medical Officer and Chief Strategy Officer through Leider Healthcare Solutions, leveraging over 25 years of executive experience in digital health and biotechnology. Previous roles include Chief Executive Officer of ZEO ScientifiX, leading innovations in regenerative medicine, and strategic advisor positions at League and Alto Pharmacy, enhancing patient engagement and pharmacy services. Harry Leider's educational background includes an MD from the University of Pennsylvania School of Medicine and an MBA from the UW Foster School of Business.
This person is not in any teams
This person is not in any offices
ZEO ScientifiX
6 followers
Based in South Florida, ZEO ScientifiX™ is a publicly traded biotechnology company committed to the research, development and manufacture of new biologic medicine, with a focus on current and potential regenerative therapeutics. ZEO ScientifiX™ is the leading, fully integrated Biologic Medicine Company. Our mission is to transform regenerative medicine through the development of novel nano-technologies and to become the health care incubator for the next generation of biologic medicines.